The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Pharmacokinetic study of olprinone hydrochloride injection in healthy volunteers
Author(s): 
Pages: 1397-1400+1403
Year: Issue:  12
Journal: Chinese Journal of New Drugs

Keyword:  olprinone hydrochloridepharmacokineticsHPLC-MS /MS;
Abstract: Objective:To investigate the pharmacokinetics of olprinone hydrochloride injection in Chinese healthy volunteers. Methods: Twelve volunteers( six men and six women) were divided into six groups by 3 × 3 design and given different doses(5,10 and 20 μg·kg- 1) of olprinone hydrochloride injection by intravenous bolus in three periods,respectively. The method of HPLC-MS / MS was used for the determination of plasma concentration of olprinone. The Phoenix TM Win Nonlin 6. 1 program was used to calculate the pharmacokinetic parameters. The urine concentration at middle dose was determined,and the excretion rate of olprinone through urinary system was calculated. Results: After single dose intravenous injection at 5,10 and 20 μg·kg- 1,the main pharmacokinetic parameters of olprinone hydrochloride injection were as follows: Cmaxwere(17. 74 ± 9. 82),(40. 31 ± 11. 80) and(75. 00 ± 31. 52) μg·L- 1,Tmaxwere( 7. 92 ± 3. 96),( 5. 42 ± 1. 44) and( 5. 00 ± 0. 00) min,t1 /2were(61. 20 ± 14. 42),(72. 01 ± 14. 40) and(69. 87 ± 14. 48) min,AUC0- t were(463. 01 ± 105. 89),(849. 54 ±149. 23) and(1 758. 35 ± 378. 46) μg·L- 1·min- 1,and AUC0- ∞were(470. 64 ± 106. 65),(863. 46 ± 153. 24)and(1 783. 07 ± 388. 52) μg·L- 1·min- 1,respectively. The accumulation excretion rate of olprinone at the medium dose in the healthy volunteers was(61. 79 ± 5. 465) %. Conclusion: Olprinone hydrochloride injection may have linear pharmacokinetic feature in the dose range of 5 ~ 20 μg·kg- 1in human body,and it is mainly eliminated through kidney.
Related Articles
loading...